PCMA Alleges Branded Drug Firms Thwarting Generics

More News:

• 03/18/2010 Teva Beats Out Pfizer & Activa in 3.5BN Rationpharm Generics DealFrom CTV.ca
• 03/18/2010 Johnson & Johnson CEO Weldon Gets 11% 2009 Raise, to $25.6MFrom AP.com
• 03/17/2010 $75 Million Drug Heist is Bitter Pill for LillyFrom IndyStar.com
• 03/17/2010 R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
• 03/15/2010 Diabetes Drug From Lilly, Amylin Under ScrutinyFrom Forbes.com
• 03/12/2010 AstraZeneca Inks First Generic Drugs DealFrom Business.timesonline.co.uk
• 03/12/2010 AstraZeneca Job Cuts Reflect New Landscape For Drug InnovationFrom FT.com
• 03/10/2010 Novartis Goes Wireless for Process and Plant Info
• 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
• 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
• All news »